Browse > Article

Effects of Soy and Isoflavones on Bone Metabolism in Growing Female Rats  

최미자 (계명대학교 식품영양학과)
조현주 (계명대학교 식품영양학과)
Publication Information
Journal of Nutrition and Health / v.36, no.6, 2003 , pp. 549-558 More about this Journal
Abstract
The purpose of this study was to determine which differences in the source of protein (soy vs casein) and isoflavones in soy protein are responsible for the differential effects of bone marks and hormones in growing female rats. Forty-two 21-day-old Sprague-Dawley female rats were randomly assigned to one of three groups, consuming casein (control group), soy protein isolate (57 mg isoflavones/100 g diet), or soy protein concentrate (about 1.2 mg isoflavones/100 g diet). All rats were fed on experimental diet and deionized water ad libitum for 9 weeks. Bone formation was measured by serum osteocalcin and alkaline phosphatase (ALP) concentrations. And bone resorption rate was measured by deoxypyridinoline (DPD) crosslinks immunoassay and corrected for creatinine. Serum osteocalcin, growth hormone, estrogen and calcitonin were analyzed using radioimmunoassay kits. Diet did not affect weight gain and mean food intake. Food efficiency ratio was lower in the soy protein groups. The soy isolate group had a higher ALP and osteocalcin concentration and lower crosslinks value than the casein group. Therefore, the soy isolate groups had a higher bone formation/resorption ratio than the casein group. And, the soy group had significantly higher growth hormone than the casein group. The findings of this study suggest that soy protein and isoflavones are beneficial for bone formation in growing female rats. Therefore, exposure to these soy protein and isoflavones early in life may have benefits for osteoporosis prevention.
Keywords
isoflavones; osteocalcin; PTH; DPD; calcitonin; growth hormone; growing female rats;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Adlercreutz H, Mazur W. Phytoestrogen and western disease. Ann Med 29: 95-120, 1997
2 Martin RM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 198: 1860-1867, 1978
3 Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72: 844-852, 2000
4 Guarnero P, Grimaux M, Seguin P, Delmas P. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Min Res 9: 692-698, 1994
5 Garmero P, Delmas PD. New developments in biochemical markers of osteoporosis. Calcif Tissue Intl 59(7): 2-9, 1996   DOI
6 Delmas PD, Stenner D, Wahner HW, Mann KG, Riggs BL. Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest 71: 1316-1321, 1983   DOI
7 Mathur SR. Effect of protein source and excercise on skeletal health of growing female rats. Dissertation of Ph.D in Texas Woman's University, 1998
8 Chae JH. The effect of isoflavones on bone mineral density and bone mineral content in growing male rats. Master's thesis, Keimyung University, 2002
9 Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86 (11) : 5217-5221, 2001   DOI
10 Jung SH. The effect of dietary protein source and sulfur amino acid content on bone metabolism in male rats. Master's thesis, Keimyung University, 1995
11 Min HK. Osteoporosis. J Korean Soc Internal Medicine 34: 442-445, 1976
12 Pfeuffer M, Wuttke, Baryh CA. Influence of different dietary proteins on plasma growth hormone in rats. Z Ernahrungggswiss 27(4): 229-35, 1988   DOI
13 Kim MS. Beneficial effect of soy isoflavone on bone loss and hyperlipidemia in ovariectomized rats. Dissertation of Ph.D, Seoul National University, 1999
14 Johnell O, Oden A, De Laet C, Garnero P, Delmas PD, Kanis JA. Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int 13: 523-526, 2002   DOI   ScienceOn
15 Murakami H, Nakamura T, Tsurukami H, Abe M, Barbier A, Suzuke K. Effects of tiludronate on bone mass, structure, and turnover, at the epiphyseal, primary, and secondary spongiosa in the proximal tibia growing rats after sciatic neurectomy. J Bone Miner Res 9: 1355-1364, 1994   DOI   ScienceOn
16 Hauschka PV, Lian JB, Dole DEC, Gundberg CM. Osteocalcin and matrix gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69: 990-1047, 1989
17 Mahan LK, Escott-Stump S. Krauses's food, nutrition & diet therapy. 9th ed. W.B. Saunders Company, Philadelphia, pp346, 1996
18 Lee DH, Lee HS, Kim MH, Yoon ME, Sung CJ. Effect of isoflavones supplementation on bone mineral density and sex hormones in postmenopausal women. Korean J Nutrition 35: 863-869. 2002
19 Kim WY. Osteoporosis and dietary factors. Korean J Nutrition 27: 636-645, 1994
20 Andreassen TT, Jorgensen PH, Flyvbjerg A, Orskov H, Oxlund H. Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res 10: 1057-1067, 1995   DOI   ScienceOn
21 Shutt DA, Cox RI. Steroid and phytoestrogen binding to sheep uterine receptors in vitro. J Endocrino 52: 299-310, 1972   DOI   ScienceOn
22 Wasnich RD. Bone mass measurements in diagnosis and assessment of therapy. Am J Med 91 (suppl5): 54s-58s, 1991   DOI   ScienceOn
23 Dwyer JT, Goldin BR, Saul N, Gualtieri L, Barakat S, Adlercreutz H. Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc 94: 739-743, 1994   DOI   ScienceOn
24 Nass R, Pezzoli SS, Chapman IM, Patrie J, Hintz RL, Hartman ML, Thorner MO. IGF-I does not affect the net increase in GH release in response to arginine. Am J Physiol Endocrinol Metab 283(4): E702-710, 2002
25 Choi MJ. Cho HJ. Effects of soy protein and isoflavones on bone mineral density in growing female rats. Korean J Nutrition 36(5) : 452-458, 2003
26 Khalil DA, Lucas EA, Juma S, Smith BJ, Payton ME, Arjmandi BH. Soy protein supplementation increases serum insulin-like growth factor-I in young and old men but does not affect markers of bone metabolism. J Nutr 132(9): 2605-2608, 2002
27 Scheiber MD, Rebar RW. Isoflavones and postmenopausal bone health. Menopause 6: 233-241, 1999   DOI   ScienceOn
28 Lian JB, Gundberg CM. Osteocalcin biochemical considerations and clinical applications. Clin Ortho Rei Res 226: 267-291, 1998
29 Arjmandi BH, Alekel L, Hollis BW. Dietary soybean protein prevents bone loss in an ovariectomized osteoporosis. J Nutr 126: 161-167, 1996
30 Monson JP, Arake WM, Carroll PV, Weaver JU, Rodriguez-Arnao J, Savage MO. Influence of growth hormone on accretion of bone mass. Horm Res 58 (Suppl) 1: 52s-56s, 2002
31 Cooper C, Campion G, Melton LJ. Hip fractures in the elderly; a world-wide projection. Osteoporosis Int 2: 285-289, 1992   DOI
32 Eyre DR. Biochemical markers of bone turnover. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 3rd ed. in: 3Favus MJ. Raven Press, New York, pp114-118, 1996
33 Uesugi T, Toda T, Tsuji K, Ishida H. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol Pharm Bull 24(4) : 368-372, 2001   DOI   ScienceOn
34 Fanti O, Faugere MC, Gang Z, Schmidt J, Cohen D, Malluche HH. Systematic administration of genistein partially prevents bone loss in ovariectomized rats in a nonestrogen-like mechanism. Am J Clin Nutr 68 (suppl): 1517s(abs), 1998
35 Dean HJ, Kellett JG, Bala RM. The effect of growth hormone treatment on somatomedin levels in growth hormone deficient children. J clin Endocrinol Metab 55: 1167-1173, 1982   DOI
36 Choi MJ. Effects of soy protein on bone mineral content and bone mineral density in growing male rats. Kor J Nutr 35(4): 409-413, 2002
37 Calvo MS, Bell RR, Forbes RM. Effect of protein-induced calciuria on calcium metabolism and bone status in adult rats. J Nutr 112: 1401-1409, 1982
38 Kim KL, Kim WY. The effect of soy protein and casein on serum lipid, amino acid. Korean J Nutr 17: 309-310, 1983
39 Miksick RJ. Estrogenic flavonoids: structural requirements for biological activity. PSEBM 208: 44-50, 1995
40 Hannon R, Blumsohn A, Dehaimi AW, Eastell R. The use of biochemical markers of bone turnover to monitor the skeletal response to hormone replacement therapy. Bone 10 (suppl2) : 549s-555s, 1995
41 Song TT, Hendrich S, Murphy PA. Estrogenic activity of glycitein, a Soy Isoflavone. J Agric Food Chem 47: 1607-1610, 1999   DOI   ScienceOn
42 Nanda N, Joshi H, Subbarao SK, Sharma VP. Two-site immuno-radiometricassay (IRMA): detection, efficiency, and procedural modifications. J Am Mosq Control Assoc 10: 225-227, 1994
43 Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW, Haussler MR. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241: 81-84, 1998   DOI
44 Kalu DN, Masoro EJ, Yu Bp, Hardin RR, Hollis BW. Modulation of age related hyperparathyroidism and senile bone loss in fischer rats by soy protein and food restriction. Endocrinology 122: 1847-1854, 1998   DOI   ScienceOn
45 Bonaccorsi G, Albertazzi P, Constantino D. Soy phytoestrogen and bone. N Am Menopause Soc Meet 44 (abstract) : 44, 1997
46 Gruber HF, Ivey JL, Baylink DJ. Long Term Calcitonin Therapy in postmenopausal osteoporosis. Metabolism 33: 295-303, 1984   DOI   ScienceOn
47 Lely AJ. Growth Hormone and aging. GH & IGF Res 9: 117-119, 1999   DOI   ScienceOn
48 Ki OH, Kim DY, Yong HI, Woo JT, Kim SW, Yang IM, Kim JW. Changes of bone turnover markers after treatment with growth retardation. J Korea Soc Endocrinol 9: 344-349, 1994
49 Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M. Stimulatory influence of soy protein isolate on breast sedretion in pre- and postmenopausal women. Cancer Epodemiol Biomarkers Prev 5: 785-794, 1996
50 Draper CR, Edel MJ, Dick IM, Randall AG, Martin GB, Raince RL. Phytoestrogens reduce bone loss and bone resorption in ophorectomized rats. J Nutr 127: 1795-1799, 1997
51 Attie KM. The importance of growth hormone replacement therapy for bone mass in young adults with growth hormone deficiency. J Pediatr Endocrinol Metab 13(suppl): 1011-1021, 2000
52 Xing S, Cekan SZ, Dicafalusy U. Validation of radioimunoassay for estadiol-17 isotope dilution-mass spectrometry and a test of radiochemical purity. Clin Chem Acta 135: 189-201, 1983   DOI   ScienceOn
53 Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents. J Nutr 123: 1939-1951, 1993
54 Delmas PD. Biological markers of bone turnover for the clinical investigation of osteoporosis. Osteoporosis Int (suppl): s81-s86, 1993   DOI
55 Picherit C, Bennetau-Pelissero C, Chanternne B, Lebecque P, Cavicco MJ, Barlet JP, Coxam V. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 131: 723-728, 2001